Biotechnology Congressional Scrutiny Intensifies On Chinese Biotech Firms: WuXi AppTec Faces Biotech Exodus – AstraZeneca (NASDAQ:AZN), Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology FDA To Review Two Cell Therapies For Multiple Myeloma This Week – Johnson & Johnson And Bristol-Myers – Johnson & Johnson (NYSE:JNJ), Bristol-Myers Squibb (NYSE:BMY) Read more
Biotechnology Golden Cross Alert: Johnson & Johnson Shines With Ambrx Deal, Bullish Technical Signal – Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology FDA Approves Johnson & Johnson’s Reduced Tecvayli Dosing In Pretreated Multiple Myeloma Patients – Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology New Hope For Patients With Chronic Autoimmune Conditions: Johnson & Johnson’s Investigational Drug Meets Primary Goal In Two Studies – Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000 – Johnson & Johnson (NYSE:JNJ), Mind Medicine (NASDAQ:MNMD) Read more